|
|
|
|
Delaware
|
|
000-31161
|
|
23-2908305
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.02
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
Exhibit No.
|
|
Description
|
10.1
|
|
Employment agreement, dated as of June 14, 2016, between Arena and Kevin R. Lind
|
10.2
|
|
Amendment No. 1, effective June 13, 2016, to Amended and Restated Severance Benefit Plan, effective May 9, 2016, and, as amended, providing benefits for Drs. Audet, Behan and Shanahan and Messrs. Lind, Mezzino and Spector
|
Date: June 15, 2016
|
Arena Pharmaceuticals, Inc.
|
||
|
|
|
|
|
By:
|
|
/s/ Amit D. Munshi
|
|
|
|
Amit D. Munshi
|
|
|
|
President and Chief Executive Officer
|
Exhibit No.
|
|
Description
|
10.1
|
|
Employment agreement, dated as of June 14, 2016, between Arena and Kevin R. Lind
|
10.2
|
|
Amendment No. 1, effective June 13, 2016, to Amended and Restated Severance Benefit Plan, effective May 9, 2016, and, as amended, providing benefits for Drs. Audet, Behan and Shanahan and Messrs. Lind, Mezzino and Spector
|
June 10, 2016
|
|
|
|
AMENDED
|
•
|
Successful completion of background verification conducted by an Arena service provider.
|
•
|
Verification of your eligibility to work in the United States, as required by the Immigration Reform and Control Act of 1986. You must complete
section 1 only
of the attached* I-9 form and provide the required documentation on your first day of employment. For assistance with employment (H-1B) visa issues, please contact Allison Anderson at extension 1737.
|
Kevin Lind
|
|
Page 2
|
June 10, 2016
|
|
|
•
|
Execution of the attached*
Employee Proprietary Information and Inventions Agreement
, which specifies your responsibilities regarding proprietary information, trade secrets and intellectual property.
|
•
|
Completion and confirmation of all other required employment and benefits forms, including the attached*
Policy-Protection of Material/Prevention of Insider Trading, IT Security and Compliance Policy, Code of Business Conduct and Ethics, Anti-Corruption Policy, Policy Against Harassment, Policy on Filing, Receipt, and Treatment of Complaints, Policy Regarding Serving of Alcohol at Company Events, Legal Hold Policy, Publication Policy, Corporate Communications Guidelines, Lab Notebook Policy, and PhRMA Code on Interactions with Healthcare Professionals.
|
Kevin Lind
|
|
Page 3
|
June 10, 2016
|
|
|
Arena Pharmaceuticals, Inc.
|
|
|
/s/ Amit D. Munshi
|
Amit D. Munshi
|
President and Chief Executive Officer
|